UK researchers track Real-World success of CLL drug acalabrutinib

NCT ID NCT05557695

Recruiting now Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 24 times

Summary

This study is not testing a new treatment—it simply observes patients with chronic lymphocytic leukemia (CLL) who already received acalabrutinib through a UK early access program. Researchers will review medical records to see how long patients went without their cancer worsening and how long they lived. The goal is to understand how well the drug works in everyday practice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
RECRUITING

Aylesbury, United Kingdom
Research Site
RECRUITING

Bath, United Kingdom
Research Site
RECRUITING

Birmingham, United Kingdom
Research Site
RECRUITING

Bournemouth, United Kingdom
Research Site
RECRUITING

Cardiff, United Kingdom
Research Site
RECRUITING

Cornwall, United Kingdom
Research Site
RECRUITING

Dartford, United Kingdom
Research Site
RECRUITING

Derby, United Kingdom
Research Site
RECRUITING

Doncaster, United Kingdom
Research Site
RECRUITING

Dorset, United Kingdom
Research Site
RECRUITING

Eastbourne, United Kingdom
Research Site
RECRUITING

Hull, United Kingdom
Research Site
RECRUITING

Leicester, United Kingdom
Research Site
RECRUITING

Lincoln, United Kingdom
Research Site
RECRUITING

Liverpool, United Kingdom
Research Site
RECRUITING

London, SE1 9RT, United Kingdom
Research Site
RECRUITING

London, W12 OHS, United Kingdom
Research Site
RECRUITING

Mid Yorkshire, United Kingdom
Research Site
RECRUITING

Middlesbrough, United Kingdom
Research Site
RECRUITING

Newcastle, United Kingdom
Research Site
RECRUITING

North Shields, United Kingdom
Research Site
RECRUITING

Norwich, United Kingdom
Research Site
RECRUITING

Nottingham, United Kingdom
Research Site
RECRUITING

Oxford, United Kingdom
Research Site
RECRUITING

Plymouth, United Kingdom
Research Site
RECRUITING

Southampton, United Kingdom
Research Site
RECRUITING

Stockton-on-Tees, United Kingdom
Research Site
RECRUITING

Stoke-on-Trent, United Kingdom
Research Site
RECRUITING

Wigan, United Kingdom

Conditions

Explore the condition pages connected to this study.

CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)